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Route of Mannheimia haemolytica and Pasteurella multocida Vaccine
Administration Does Not Affect Health or Performance of Receiving Heifers
Abstract
Light weight stocker calves often experience health problems shortly after arrival to feeding facilities.
Preventative health programs are routinely administered to calves upon arrival to reduce the incidence of
Bovine Respiratory Disease. The major route of vaccine administration in cattle is via injection through
either intramuscular or subcutaneous routes. Several products have been introduced that utilize the
intranasal route of vaccine administration. There are several reasons why intranasal vaccine
administration may be more beneficial: 1) Intranasal vaccine administration alleviates concerns that
injections pose for Beef Quality Assurance programs. 2) Intranasal vaccine administration may be less
stressful on the animal. 3) Intranasal vaccine administration delivers the vaccine to the site of infection in
the case of respiratory pathogens, and may provide a different adaptive immune response to the vaccine.
The objective of this study was to determine the effects of route of administration of the Mannheimia
haemolytica and Pasteurella multocida fractions of the vaccine regimen on receiving cattle growth
performance, health, and mortality.

Keywords
intranasal vaccine, health, stocker

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Authors
T. Spore, M. E. Corrigan, T. R. Parks, C. S. Weibert, M. L. DeTray, W. R. Hollenbeck, R. N. Wahl, and Dale
Blasi

This beef cattle management is available in Kansas Agricultural Experiment Station Research Reports:
https://newprairiepress.org/kaesrr/vol3/iss1/5

Cattlemen's
Day 2017

S STATE UNIVERS
ITY
NSA
KA

C AT T

LEMEN’S DAY

Route of Mannheimia haemolytica
and Pasteurella multocida Vaccine
Administration Does Not Affect Health or
Performance of Receiving Heifers
T.J. Spore, M.E. Corrigan1, T.R. Parks1,C.S. Weibert, M.L. DeTray,
W.R. Hollenbeck, R.N. Wahl, and D.A. Blasi

Introduction

Light weight stocker calves often experience health problems shortly after arrival to
feeding facilities. Preventative health programs are routinely administered to calves
upon arrival to reduce the incidence of Bovine Respiratory Disease. The major route of
vaccine administration in cattle is via injection through either intramuscular or subcutaneous routes. Several products have been introduced that utilize the intranasal route
of vaccine administration. There are several reasons why intranasal vaccine administration may be more beneficial: 1) Intranasal vaccine administration alleviates concerns
that injections pose for Beef Quality Assurance programs. 2) Intranasal vaccine administration may be less stressful on the animal. 3) Intranasal vaccine administration
delivers the vaccine to the site of infection in the case of respiratory pathogens, and may
provide a different adaptive immune response to the vaccine.
The objective of this study was to determine the effects of route of administration of the
Mannheimia haemolytica and Pasteurella multocida fractions of the vaccine regimen on
receiving cattle growth performance, health, and mortality.
Key words: intranasal vaccine, health, stocker

Experimental Procedures

A total of 388 cross-bred heifers (497 ± 32 lb) were purchased from sale barns in MO
and TN and received in 4 truckloads to the Kansas State University Beef Stocker Unit.
Two truckloads were received on March 23, one truckload was received on March 30,
and one truckload was received on April 2, 2016. Cattle were weighed immediately after coming off the truck, individually identified with an ear tag, and an ear notch sample
was taken for testing of persistent infection with Bovine Viral Diarrhea Virus. Three
animals tested positive and were excluded from the experiment. Other exclusion criteria
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included the presence of active disease, injury, or disparities in body weight relative to
the other animals from the truckload.
The day following arrival, all cattle were weighed again and given their respective investigational vaccines and Vision 7 Somnus (Merck Animal Health, Madison, NJ), Ivomec
Plus (Merial, Duluth, GA), Safe-Guard (Merck Animal Health, Madison, NJ) and
Exede (Zoetis, Parsippany, NJ). This weight served as the initial weight for the experiment.
Truckload served as the blocking factor and cattle within a truckload were stratified by
arrival weight and randomly assigned to pens of 11 to 13 head. Pens were then randomly assigned to one of 2 treatments with 16 pens per treatment. Treatments consisted of
Vista Once SQ (Merck Animal Health, Madison, NJ) given subcutaneously at initial
processing or Vista 5 SQ (Merck Animal Health, Madison, NJ) given subcutaneously
plus Once PMH IN (Merck Animal Health, Madison, NJ) administered intranasally at
initial processing.
Diets were provided in quantities to ensure ad libitum intake. Body weights were
captured at initial processing, during revaccination (day 14), and at completion of the
study, which was day 47 for blocks 1 and 2 and day 45 for blocks 3 and 4. All calves
were observed daily for any signs of sickness or lameness. If any signs were observed,
cattle were pulled from their pens and a rectal temperature was taken. If a temperature
of 104°F or higher was found, antibiotics were administered according to the Kansas
State University Beef Stocker Unit health protocol. Diagnosis of non-bovine respiratory diseases (lameness, pink eye, etc.) was treated according to the health protocol.
During the course of the trial, 1 animal from the Vista Once SQ group was found
dead in the pen from bronchopneumonia. Additionally, 4 heifers were removed for
mycoplasma infections or injury. Of these animals, 2 were in the Vista Once SQ group
and 2 were in the Vista 5 SQ plus Once PMH IN group. These animals were excluded
from the analysis. Data were analyzed as a randomized complete block design using the
MIXED procedure of SAS (version 9.3; SAS Institute, Cary, NC). Pen was the experimental unit. In the model, treatment was a fixed effect and block was a random effect.
Treatment differences were considered significant at P-value less than 0.05 and tendencies at P-value less than 0.10.

Results and Discussion

The effects of route of vaccine administration are shown in Table 1. Overall, the cattle
performed well on feed between all treatments. There were no differences in body
weight gain, average daily gain, feed intake, feed efficiency, morbidity, or mortality during the receiving trial. Morbidity and mortality were lower than anticipated in this class
of cattle.

Implications

Route of vaccine administration in cattle experiencing a low disease challenge did not
impact performance or health measurements.
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Table 1. Performance and health of cattle vaccinated with VISTA Once SQ given subcutaneously or VISTA 5 SQ given subcutaneously together with ONCE PMH-IN administered intranasally
Vista 5 SQ and
Item
Once PMH IN Vista Once SQ
SEM1
P-value
Initial weight, lb
498
499
1.3
0.77
14-Day performance
Body weight, lb
Dry matter intake, lb
Average daily gain, lb
Gain:feed

534
10.8
2.53
0.232

531
11.0
2.32
0.212

2.8
0.13
0.196
0.0181

0.39
0.36
0.29
0.25

45-Day performance
Final weight, lb
Dry matter intake, lb
Average daily gain, lb
Gain:feed

593
11.9
2.06
0.174

593
12.0
2.05
0.171

3.9
0.13
0.083
0.0069

0.96
0.50
0.83
0.66

Health
1st Pulls
2nd Pulls
Mortality

4.1%
0.01%
0%

3.6%
0.01%
0.005%

0.17
0.008
0.0064

0.73
0.55
1.00

SEM=Standard error of the mean.
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